A novel, covalent and highly synthetically accessible SARS-CoV-2 Mpro chloroacetamide inhibitor
Zagribelnyy, B., Zhavoronkov, A.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
3C-like proteinase | 305 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0  EC: 3.4.22.69 | ![]() | |
UniProt | |||||
Find proteins for P0DTD1 (Severe acute respiratory syndrome coronavirus 2) Explore P0DTD1  Go to UniProtKB:  P0DTD1 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P0DTD1 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 3 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
A1MBL (Subject of Investigation/LOI) Query on A1MBL | B [auth A] | (2~{R})-~{N}-[4,4-bis(fluoranyl)cyclohexyl]-2-[ethanoyl-[4-(1,2-thiazol-5-yl)phenyl]amino]-2-pyrazin-2-yl-ethanamide C23 H23 F2 N5 O2 S XBLRWHTTYHELQM-OAQYLSRUSA-N | |||
EDO Query on EDO | D [auth A] E [auth A] F [auth A] G [auth A] H [auth A] | 1,2-ETHANEDIOL C2 H6 O2 LYCAIKOWRPUZTN-UHFFFAOYSA-N | |||
ACT Query on ACT | C [auth A] | ACETATE ION C2 H3 O2 QTBSBXVTEAMEQO-UHFFFAOYSA-M |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 44.83 | α = 90 |
b = 63.37 | β = 90 |
c = 106.81 | γ = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
Funding Organization | Location | Grant Number |
---|---|---|
Not funded | -- |